COVID-19 Antibody Testing - Apex Benefits

COVID-19 Antibody Testing

MACL | Apex Benefits

COVID-19 Antibody Testing Program for Employers

Apex has partnered with Mid America Clinical Labs (MACL) to offer testing that helps to determine if someone was infected with the SARS-CoV-2 (COVID-19) virus and has developed antibodies against the virus.

As you are developing your Return to the Workplace Safety plan, you may be considering COVID-19 testing for your employees. While nasal swab testing is readily available for front-line workers, those at highest risk and those exhibiting symptoms, we are seeing growing demand for antibody testing.

The antibody test (blood test) determines whether or not a person has had the virus in the past, while the viral test (nasal swab) determines if the person currently has the virus.

Previously only available to healthcare service providers, the test is being made available by MACL to Central Indiana employers in partnership with Apex.

Employers can receive a nearly 20% discount per test for their employees. To receive this discount, employers must register through the form on this page.



What is an antibody?

An antibody is a protein that the body produces in the late stages of infection. It may not exhibit for several weeks after ingestion yet could remain in a person’s system for months or years after they’ve recovered.

What is the purpose of this test?

Detecting these antibodies will help determine if a person was previously infected with the virus that causes COVID-19. In the long term, this data may enable scientists to better understand how long these antibodies stay in the body and if they provide immunity, which could help support the development of treatments/vaccines.

Where can I learn more about antibody testing?
Who is Mid America Clinical Labs?

Mid America Clinical Laboratories, LLC (MACL) is a joint venture company owned by and in partnership with Community Hospital, St. Vincent Hospital, Quest Diagnostics and CoLab. They are the largest clinical laboratory in Indiana, completing over 4.5 million tests per year.